Karyopharm Therapeutics I... (KPTI)
7.24
-0.71 (-8.93%)
At close: Mar 03, 2025, 3:59 PM
7.61
5.11%
After-hours: Mar 03, 2025, 04:01 PM EST
Karyopharm Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -16.17 | -10.36 | -25.26 | -58.46 | -85.23 | -89.26 | -44.73 | -51.24 | -48.28 | -59.9 | -230.69 | -61.45 | -36.25 | -23.45 |
| PEG Ratio | 0.33 | 0.27 | -1.13 | 1.49 | 5.49 | -35.03 | -3.81 | 13.60 | 4.01 | -1.64 | 4.08 | 3.89 | 1.03 | n/a |
| PS Ratio | 8.51 | 10.15 | 26.58 | 34.58 | 154.77 | 435.66 | 263.07 | 4.12K | 34.36K | 28.32K | 76.34K | 5.39K | 908.54 | 1.59K |
| PB Ratio | -6.64 | -10.88 | -250.69 | -91.06 | 330.96 | 357.92 | 43.57 | 51.05 | 32.61 | 35.69 | 84.53 | 13.46 | -20.66 | -19.11 |
| P/FCF Ratio | -9.68 | -15.99 | -27.9 | -64.3 | -104.31 | -93.26 | -49.42 | -89.59 | -62.64 | -74.17 | -322.05 | -68.74 | -36.85 | -27.09 |
| P/OCF Ratio | -9.69 | -15.99 | -27.92 | -67.73 | -104.4 | -93.36 | -50.15 | -89.66 | -62.69 | -75.29 | -339.79 | -68.87 | -37.14 | -28.28 |
| OCF/S Ratio | -0.88 | -0.63 | -0.95 | -0.51 | -1.48 | -4.67 | -5.25 | -45.93 | -547.99 | -376.12 | -224.66 | -78.27 | -24.46 | -56.24 |
| Debt / Equity Ratio | -0.54 | -1.3 | -10.39 | -2.12 | 2.33 | 2.21 | 0.56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 1.64 | 3.32 | 4.89 | 3.45 | 965.98 | 5.90 | 7.13 | 3.00 | 7.99 | 11.74 | 16.89 | 54.32 | 0.49 | 3.24 |
| Current Ratio | 1.70 | 3.37 | 4.96 | 3.50 | 974.88 | 5.90 | 7.13 | 3.00 | 7.99 | 11.74 | 16.89 | 54.32 | 0.49 | 3.24 |
| Asset Turnover | 0.88 | 0.61 | 0.44 | 0.69 | 0.35 | 0.14 | 0.09 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 | 0.02 |
| Interest Coverage | -3.19 | -5.44 | -5.69 | -3.77 | -6.33 | -12.1 | -72.16 | n/a | n/a | n/a | -75.85K | n/a | n/a | n/a |
| Return on Equity (ROE) | 0.41 | 1.05 | 9.92 | 1.56 | -3.88 | -4.01 | -0.97 | -1 | -0.68 | -0.6 | -0.37 | -0.22 | 0.57 | 0.82 |
| Return on Assets (ROA) | -0.46 | -0.6 | -0.46 | -0.41 | -0.63 | -0.68 | -0.52 | -0.72 | -0.61 | -0.55 | -0.34 | -0.21 | -12.12 | -1.43 |
| Return on Capital (ROIC) | -1.66 | -0.76 | -0.49 | -0.42 | -0.55 | -0.76 | -0.61 | -1 | -0.68 | -0.59 | -0.36 | -0.22 | 25.67 | -2.02 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 95.86% | 96.62% | 96.68% | 98.38% | 97.50% | 94.11% | -431.95% | -6.58K% | -56.35K% | -39K% | -26.16K% | -7.25K% | -2.12K% | 100.00% |
| Net Profit Margin | -52.62% | -97.99% | -105.23% | -59.14% | -181.59% | -488.08% | -588.1% | -8.04K% | -71.15K% | -47.27K% | -33.09K% | -8.77K% | -2.51K% | -6.78K% |
| Pretax Profit Margin | -52.58% | -97.77% | -105% | -59.01% | -181.31% | -487.98% | -588.02% | -8.03K% | -71.06K% | -47.27K% | -33.09K% | -8.77K% | -2.51K% | -6.78K% |
| Operating Profit Margin | -82.24% | -88.71% | -90.53% | -46.84% | -159% | -462.85% | -592.97% | -8.13K% | -71.9K% | -47.63K% | -33.12K% | -8.77K% | -2.51K% | -6.78K% |
| FCF Margin | -87.88% | -63.49% | -95.29% | -53.77% | -148.38% | -467.14% | -532.3% | -4.6K% | -54.84K% | -38.18K% | -23.7K% | -7.84K% | -2.47K% | -5.87K% |
| EBITDA Margin | -26.58% | -81.09% | -88.69% | -46.22% | -155.3% | -447.34% | -577.38% | -7.99K% | -70.6K% | -47.38K% | -32.95K% | -8.73K% | -2.49K% | -6.73K% |